e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

16.85p
   
  • Change Today:
      0.38p
  • 52 Week High: 33.80
  • 52 Week Low: 15.48
  • Currency: UK Pounds
  • Shares Issued: 582.16m
  • Volume: 18,272
  • Market Cap: £98.09m
  • Beta: 0.03

e-Therapeutics Overview

e-Therapeutics is in the pharma and biotech sector and is currently trading at 16.85p per share. In the last year e-Therapeutics's share price has ranged from 15.48p to 33.80p.

1 Day Chart (06-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2006.3% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 205.6 n/a
Pr/Book 3.5  
Latest F'cast
Revenue 50.5% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

e-Therapeutics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-18 n/a (6.72) (2.00)p n/a n/a n/a n/a 0.0%
31-Jan-19 0.04 (5.09) (1.49)p n/a n/a n/a n/a 0.0%
31-Jan-20 0.46 (2.87) (0.87)p n/a n/a n/a n/a 0.0%
31-Jan-21 0.32 (4.47) (0.99)p n/a n/a n/a n/a 0.0%
31-Jan-22 0.48 (9,519.00) (1.65)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

e-Therapeutics Company Announcements

Total Voting Rights 31-Jan-2023 07:00 RNS
Director Dealing and Issue of Equity 04-Jan-2023 15:15 RNS
Second Price Monitoring Extn 29-Dec-2022 16:40 RNS

e-Therapeutics ShareCast News

Eight new patent applications filed by e-therape... 01-Aug-2022 ShareCast
E-therapeutics reaches 'key milestone' in Galapa... 12-Apr-2022 ShareCast
E-therapeutics finance chief stepping down due t... 22-Nov-2021 ShareCast

Latest e-Therapeutics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 16.85p
Change Today 0.38p
% Change 2.28 %
52 Week High 33.80
52 Week Low 15.48
Volume 18,272
Shares Issued 582.16m
Market Cap £98.09m
Beta 0.03

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.6% below the market average30.6% below the market average30.6% below the market average30.6% below the market average30.6% below the market average
13.79% above the sector average13.79% above the sector average13.79% above the sector average13.79% above the sector average13.79% above the sector average
Price Trend
67.58% below the market average67.58% below the market average67.58% below the market average67.58% below the market average67.58% below the market average
Sector averageSector averageSector averageSector averageSector average
Income Not Available
Growth
37.94% above the market average37.94% above the market average37.94% above the market average37.94% above the market average37.94% above the market average
55.00% above the sector average55.00% above the sector average55.00% above the sector average55.00% above the sector average55.00% above the sector average

e-Therapeutics Dividends

No dividends found

Trades for 06-Feb-2023

Time Volume / Share Price
16:28 5 @ 17.20p
12:21 2,943 @ 16.99p
10:07 3,000 @ 16.86p
09:46 11,795 @ 16.86p
08:43 29 @ 17.15p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page